about
Protection against pulmonary oxygen toxicity by interleukin-1 and tumor necrosis factor: role of antioxidant enzymes and effect of cyclooxygenase inhibitorsTransfer factor — Current status and future prospectsAIDS and transfer factor: myths, certainties and realities.Therapeutic evaluation of interleukin-1 for stimulation of hematopoiesis in primates after autologous bone marrow transplantation.The therapeutic potential of interleukin-1 beta in the treatment of chemotherapy- or radiation-induced myelosuppression and in tumor therapy.A phase I trial of recombinant tumor necrosis factor (rTNF) administered by continuous intravenous infusion in patients with disseminated malignancy.Chimeric antibody: potential applications for drug delivery and immunotherapy.Interleukin-2. The experience of the Rotterdam Cancer Institute; Daniel den Hoed Kliniek.Interleukin-3.Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study.Tissue distribution and cellular distribution of liposomes encapsulating muramyltripeptide phosphatidyl ethanolamide. Tissue and cellular distribution of LE-MTPPE.Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study.Dialyzable lymphoid extract (DLE) from mice resistant to STZ-induced diabetogenesis can interrupt the progress of diabetes in STZ-treated CD-1 mice.Somatostatin and growth hormone regulation in cancer.Antigen-specific, MHC-unrestricted T cells.Functional and morphologic characterization of human T lymphocytes expressing the TCR gamma/delta.Implications of HIV-specific cytotoxic T lymphocytes in AIDS.Tumor-infiltrating lymphocytes as antitumor effector cells.Cytolytic T lymphocytes: an overview of their characteristics.The potential improvement of thrombolytic therapy by targeting with bispecific monoclonal antibodies: why they are used and how they are made.Leucoagglutinin induces differential proliferation of lymphocyte subsets.Adoptive immunotherapy of cancer: biological response modifiers and cytotoxic cell therapy.Spontaneous regression of cancer: new insights.Glucocorticoids in cancer therapy.Inhibiting tissue invasion and metastasis as targets for cancer therapy.Characteristics and uses of IL-2 in immunotherapy.Treatment of gastrointestinal and renal adenocarcinomas with interferon-alpha.Strategies for improving antitumor activity utilizing IL-2: preclinical models and analysis of antitumor activity of lymphocytes from patients receiving IL-2.MTP-PE in liposomes as a biological response modifier in the treatment of cancer: current status.Clinical trials of bestatin for leukemia and solid tumors.Development of immunotherapeutic strategies for the treatment of malignant neoplasms.Hyperthermia in cancer growth regulation.Structure of tumor necrosis factor and its receptor.Hematopoietic growth factors in the treatment of patients with HIV infection.G-CSF and M-CSF: from molecular biology to clinical application.Liposomes and biotherapeutics.Rationale for targeted drug delivery.Liposomal delivery of biological response modifiers to macrophages.Clinical experience of targeted therapy.Delivery systems for gene therapy.
P1433
Q28341723-FD9F55A1-1E3F-4EBE-8EB6-981D9E9243A3Q29039002-40E62B97-A60E-48EE-90EF-BB773A5B2584Q30426241-FE848670-4EB2-4375-9F87-E81530F99B2BQ33368940-A009EE94-323E-494B-9FC7-94565E493898Q33426307-2A42012B-3BF9-4005-85C9-C03F553EFE3EQ33426324-31A2F3E9-6719-42C2-AB8D-4599585BFB40Q33525664-7F19B855-054F-4A4C-8A37-3413681F8C3BQ33857592-E8C72558-5481-4E44-A62C-4431B8BE21F8Q34280322-04C15ADA-455D-4708-B595-8B63D210C8B4Q34413137-363D64E6-A138-4F8D-8A86-7E55CF14C06CQ34726603-F36C2351-C505-4102-858C-96DED370F14AQ34729804-C01A0580-3D17-40C2-A320-7C7C2F9408AEQ34737379-C1378B8A-C5A0-46B0-89F4-F711E12245C0Q35251198-B5E0D23F-45B2-42E1-91AA-5FE40127A3CFQ35325886-84C084D3-7180-4111-ABDC-7301FBFB7091Q35357049-D4D70366-3FE2-4F14-A1DA-36E51692BA55Q35357068-EA89EEFD-5DB6-4ACD-B6B0-A6C15BD9E333Q35357092-96609E91-5252-4B0B-BA1C-6D7B3C8102F9Q35357110-035F791C-D649-41B2-8343-A38D4B632927Q35457071-0FA13AA2-F713-4C94-B146-5A19807CE032Q35577285-55EC9C90-F556-4098-BA78-B7E41F57DF1EQ35834006-EE9A2962-A260-4CF1-B00E-2CE1F22D24F8Q35900522-AA31A6E0-3424-4DFE-8374-4C76FC0259ADQ35900526-33F4D755-5B50-435D-9682-705EF3483C8BQ35900530-4D6E08D3-03EA-4535-B39E-D643E663720CQ35971191-2E0065A9-60C7-4038-91CC-5CC797BF3823Q36184037-92A9E833-5B53-4E4D-B607-1DF31946F315Q36184041-DB12E5F1-1893-4C9C-9E18-55AB2A1A1F07Q36184046-E79B7DB2-636F-42CE-ABEE-2E5DBF7A1F50Q36184049-F375A30C-D535-4C46-8CE9-3CC1A7A6AFAAQ36184052-320F46B6-2DB6-46F5-A427-8D8FAE3280F1Q36287605-7491EF01-42B1-4636-B40D-781F92050AFEQ36393307-D1E18B85-07AD-4067-B8D3-C94D360A8BA7Q36596470-4E43B6CB-9B67-4D90-B8FA-CD1A16E2394DQ36616692-49534856-7975-42E4-92DE-F91306012F86Q36636533-D9EBD833-6A6B-4320-B99A-991C1DFEA478Q37679152-5D723A30-9E67-458D-A07E-3B9040CE278CQ37679157-8DE39525-2DCF-4884-AA05-833F23326D03Q37679162-AB2D6BC2-9CDE-40E8-9A4C-8D5F19B6C09DQ37679164-605E0728-0CE8-490D-B58C-23B57889048E
P1433
description
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
scientific journal
@en
wetenschappelijk tijdschrift van Springer International Publishing
@nl
wissenschaftliche Fachzeitschrift
@de
науковий журнал
@uk
name
Biotherapy (Dordrecht, Netherlands)
@ast
Biotherapy (Dordrecht, Netherlands)
@de
Biotherapy (Dordrecht, Netherlands)
@en
Biotherapy (Dordrecht, Netherlands)
@es
Biotherapy (Dordrecht, Netherlands)
@fr
Biotherapy (Dordrecht, Netherlands)
@it
Biotherapy (Dordrecht, Netherlands)
@nl
type
label
Biotherapy (Dordrecht, Netherlands)
@ast
Biotherapy (Dordrecht, Netherlands)
@de
Biotherapy (Dordrecht, Netherlands)
@en
Biotherapy (Dordrecht, Netherlands)
@es
Biotherapy (Dordrecht, Netherlands)
@fr
Biotherapy (Dordrecht, Netherlands)
@it
Biotherapy (Dordrecht, Netherlands)
@nl
altLabel
Biotherapy
@en
prefLabel
Biotherapy (Dordrecht, Netherlands)
@ast
Biotherapy (Dordrecht, Netherlands)
@de
Biotherapy (Dordrecht, Netherlands)
@en
Biotherapy (Dordrecht, Netherlands)
@es
Biotherapy (Dordrecht, Netherlands)
@fr
Biotherapy (Dordrecht, Netherlands)
@it
Biotherapy (Dordrecht, Netherlands)
@nl
P3181
P1055
P1156
21100829249
P1476
Biotherapy (Dordrecht, Netherlands)
@en